Mycoflu

Mycoflu Injection is fungicidal in nature, it acts by killing the fungus

Mycoflu Injection is not light sensitive

Liposomal Mycoflu Injection is a lipid-associated formulation. Liposomal encapsulation or incorporation into a lipid complex of Mycoflu Injection can substantially improves drug safety especially nephrotoxicity associated with the drug

Yes, Mycoflu Injection is an antifungal antibiotic for the treatment of serious infections caused by fungi like fungal infections of one or more deep organs of the body, suspected fungal infections in patients with a raised temperature and neutropenia (reduced number of white blood cells [neutrophils]) and Visceral leishmaniasis (disease caused by a parasite)

Yes, administration of Mycoflu Injection is associated with allergy (severe and serious allergic) reaction, therefore it is recommended to administer a test dose before starting the therapy to check for sensitivity

Mycoflu Injection is either administered as intravenous injection or infusion by a registered medical professional only

Mycoflu Injection can disrupt the lipid components of human kidney cells, thereby causing nephrotoxicity. The exact mechanism of hypokalemia is not known, but kidney damage may result in excessive loss of potassium in urine.